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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.08.062Objective: The occurrence of a seizure after the arterial switch operation is associ-
ated with a worse long-term neurodevelopmental outcome. The significance of
seizures after neonatal and infant repair of other congenital heart defects is not
known.
Methods: A recent study at our institution demonstrated seizures documented by
48-hour electroencephalographic monitoring in 20 (11%) of 178 neonates and
infants after surgery for complex congenital heart defects, including hypoplastic left
heart syndrome or variants. The developmental outcomes of this cohort were
evaluated at 1 year of age by using the Bayley Scales of Infant Development II,
which yields 2 scores: the Mental Developmental Index and the Psychomotor
Developmental Index.
Results: Developmental evaluations were performed in 114 (70%) of 164 survivors,
including 36 with hypoplastic left heart syndrome. Postoperative electroencephalo-
graphic seizures had occurred in 15 (13%) of 114 of the entire group and in 8 (22%)
of 36 of those with hypoplastic left heart syndrome. For the entire cohort, the Mental
Developmental Index was 92.3 13.5, and the Psychomotor Developmental Index was
79.9 18.8 for patients without seizures, compared with 90.3 10.7 and 74.4 19.3
for those with seizures (both P  .5). For the hypoplastic left heart syndrome
subgroup, the Mental Developmental Index was 92.3  14.9, and the Psychomotor
Developmental Index was 74.8  19.3 for patients with seizures, compared with
91.9  12.4 and 73.9  18.3 for those without seizures (both P  .5). A frontal
onset of seizures was predictive of a lower score on the Psychomotor Developmen-
tal Index, but not on the Mental Developmental Index.
Conclusions: The occurrence of a seizure after cardiac operation is a marker of
central nervous system injury. However, in this cohort of neonates and infants with
complex congenital heart defects, the occurrence of a seizure was not predictive of
a worse developmental outcome at 1 year of age as assessed by the Bayley Scales
of Infant Development II.
T he occurrence of a seizure in the early postoperative period after repair orpalliation of congenital heart defects (CHD) is a marker for a central nervoussystem (CNS) injury and has been associated with adverse neurodevelop-
mental sequelae.1-3 The research standard for detection and quantification of post-
operative seizures remains continuous electroencephalographic (EEG) monitoring.
In the Boston Circulatory Arrest Study conducted between 1988 and 1992, contin-
uous EEG monitoring in the first 48 hours after the arterial switch operation for
transposition of the great arteries (TGA), with or without a ventricular septal defect
(VSD), demonstrated seizures in 27 (20%) of 136 neonates and infants.1 Follow-up
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Devaluation of the patients in the Circulatory Arrest Study
demonstrated that the occurrence of a postoperative EEG
seizure was associated with a worse neurodevelopmental
outcome at 1 and 4 years of age.2,3 A recent study from our
institution demonstrated that the frequency of postoperative
EEG seizures was less than reported in previous studies.1,4,5
EEG seizures were identified in 11.2% of a heterogeneous
cohort of neonates and infants with complex CHDs, includ-
ing hypoplastic left heart syndrome (HLHS). An increasing
duration of deep hypothermia and circulatory arrest (DHCA)
was identified as a predictor of seizures. However, the inci-
dence of seizures in children with a limited duration of DHCA
was similar to that in infants who underwent continuous
cardiopulmonary bypass (CPB) alone. This study was un-
dertaken to evaluate the effect of postoperative EEG sei-
zures on neurodevelopmental outcome at 1 year of age in
this cohort.
Patients and Methods
Sample
A subgroup of children enrolled in a prospective study evaluat-
ing polymorphisms of apolipoprotein E (APOE) as a risk factor
for neurodevelopmental dysfunction also underwent continuous
video-EEG monitoring in the early postoperative period.6 Pa-
tients 6 months of age or younger who underwent CPB with or
without DHCA for repair of CHD were eligible. Exclusion criteria
included (1) multiple congenital anomalies, (2) a recognizable
genetic or phenotypic syndrome other than chromosome 22q11
microdeletions, and (3) a language other than English spoken in
the home. The study was approved by the Institutional Review
Board at The Children’s Hospital of Philadelphia. Informed con-
sent was obtained from the parent or guardian.
Operative Management
Operations were performed by 5 cardiac surgeons with a dedicated
team of cardiac anesthesiologists. Alpha-stat blood gas manage-
ment was used. Pump flow rates were not standardized for this
study. DHCA was used at the surgeon’s discretion. Before DHCA,
patients underwent core cooling with topical hypothermia of the
head to a nasopharyngeal temperature of 18°C. Modified ultrafil-
Abbreviations and Acronyms
APOE  apolipoprotein E
CHD  congenital heart defect
CNS  central nervous system
CPB  cardiopulmonary bypass
DHCA deep hypothermia and circulatory arrest
EEG  electroencephalogram
HLHS  hypoplastic left heart syndrome
MDI Mental Developmental Index
PDI  Psychomotor Development Index
TGA  transposition of the great arteries
VSD  ventricular septal defecttration was performed in all patients.
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Details of the video-EEG evaluation have been previously pub-
lished.5,7 Video-EEGs were recorded on 1 of 3 identical dedicated
portable Telefactor Millenium Beehive machines (Conshohocken,
Pa), which capture time-synchronized video images and digital
EEG data. A brief 15-minute preoperative baseline study was
recorded. Recording was reinitiated after surgery immediately after
admission to the cardiac intensive care unit. Video-EEGs were re-
corded continuously for the first 48 hours after surgery. Studies were
terminated only for early death or at parental request. Each record
was visually reviewed in its entirety every 24 hours by the record-
ing EEG technologist and independently by a pediatric neurologist.
The number of seizures during the study period was recorded. In
addition, the sites of origin of the seizures were recorded and
classified as frontal or nonfrontal. After confirmation of the pres-
ence of seizures, the attending physician was informed of the
occurrence of a seizure. All treatment decisions, including the
institution of antiepileptic drug therapy, were made at the discre-
tion of the attending physician.
Data Collection
Preoperative factors including gestational age, birth head circum-
ference, birth weight, Apgar scores, and preoperative intubation
were obtained from birth and hospital records. Weight, age at
operation, and type of operation were recorded along with perfu-
sion data, including CPB time, aortic crossclamp time, and dura-
tion of DHCA. Total support time was calculated as CPB time plus
DHCA time. Total DHCA time was calculated as the sum of the
duration of each episode of DHCA.
One-Year Neurodevelopmental Examination
Children were scheduled for their 1-year follow-up visit as they
approached 1 year of age. A 2-week window was established so
that children were seen at 12 months plus or minus 2 weeks.
Children born before 37 weeks of gestation were seen at their
corrected age. The developmental assessment was performed first,
followed by a medical history and physical and neurologic exam-
inations. The developmental assessment included the Bayley
Scales of Infant Development II, which yields scores on 2 indices:
the Psychomotor Development Index (PDI) and the Mental De-
velopmental Index (MDI). The medical evaluation included an
interim health history and physical examination. The neurologic
examination included neuromuscular status, reflexes, and bulbar
function. Growth measurements, including weight, length, and
head circumference, were obtained. Patients were also evaluated
by a genetic dysmorphologist. Chromosomal analysis and testing for
microdeletions of chromosome 22q11 were performed as indicated.
Recognition of neonatal dysmorphic features may be difficult; there-
fore, some patients were enrolled in whom the diagnosis of a genetic
syndrome was not made until the 1-year evaluation. Results were
classified as no definite genetic syndrome or chromosomal abnor-
mality (normal), a definite genetic syndrome or chromosomal
abnormality (abnormal), or a suspected genetic syndrome or ab-
normality (suspect).
Data Analysis and Statistical Methods
Patients were coded according to a previously described classifi-
cation that incorporates cardiac anatomy and perioperative physi-
ary 2006
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Dology and that has been shown to be predictive of perioperative
mortality.8 Class I indicates 2 ventricles with no aortic arch ob-
struction, class II indicates 2 ventricles with aortic arch obstruc-
tion, class III indicates a single ventricle with no arch obstruction,
and class IV indicates a single ventricle with arch obstruction.
Patients with tetralogy of Fallot and TGA are class I, whereas
patients with HLHS and variants are class IV. Data are presented
as median (range).
Tests for differences in the demographic characteristics of
children who did return for their 1-year follow-up versus those
who did not were conducted by using the Student t test for
qualitative predictors and 2 or Fisher exact tests for qualitative
predictors for the entire cohort and for the subgroup of patients
with HLHS or variants (class IV). The 2 test was used to test the
effects of seizure status on neuromuscular outcome unless cell
sizes were less than 5 in a 2  2 table; then the Fisher exact test
was used. To determine whether the number of seizures was
predictive of worse outcome, analysis of variance was used to
compare data for significant effects of number of seizures on MDI
and PDI. The Student t test was used to test the effects of seizure
location (frontal vs nonfrontal) on MDI and PDI, and the 2 test or
Fisher exact test was used for neuromuscular outcome. All tests
were 2-sided.
Results
Study Population
Between September 16, 2001, and April 2, 2003, 238 eligible
infants underwent cardiac operation. Of these, 209 (88%)
TABLE 1. Characteristics of patients who returned and tho
Variable
Retu
Sex
Male
Female
Gestational age (wk)
Birth weight (g)
Apgar score at 5 min
Diagnostic class
I
II
III
IV
Age at first operation (d)
Aged 30 d at first operation
Number of operations with CPB during first year
Number of episodes of DHCA during first year
1
2
3
Total support during first year (CPB  DHCA) (min)
Total DHCA during first year (min)
EEG seizures
CPB, Cardiopulmonary bypass; DHCA, deep hypothermia and circulatory aenrolled in the study of APOE genotype. Continuous post-
The Journal of Thoracioperative EEG monitoring was performed in 183 (88%). All
patients enrolled in the APOE study were approached for
enrollment in the EEG study. Reasons for not undergoing
EEG monitoring included parental refusal and unavailabil-
ity of an EEG monitor.
Complete 48-hour EEG studies were obtained in 178
patients (97%). There were 5 hospital deaths (5/178; 3%)
and 9 additional deaths (9/173; 12%) before 1 year of age.
Of the 164 patients alive at 1 year of age, 114 (70%)
returned for evaluation. Characteristics of patients who re-
turned and those who were alive at 1 year and did not return
are shown in Table 1. The only significant difference be-
tween the 2 groups was that patients with seizures were
more likely to return for evaluation.
The study population included 7 patients with TGA, 16
patients with tetralogy of Fallot, 23 patients with VSD (with
or without coarctation), 36 patients with HLHS or variants,
7 patients with other forms of functional single ventricle,
and 25 patients with a variety of other 2-ventricle cardiac
defects. Postoperative seizures had been identified in 15
(13%) of the 144 patients, including 8 (22%) of the 36
patients with HLHS or variants. Seizures had not been
identified in any of the patients with TGA or VSD and had
been identified in only 1 of the patients with tetralogy of
Fallot. Seizures had occurred in 2 of 7 patients with other
forms of functional single ventricle. The mean number of
ho were alive at 1 year and did not return
for 1-y evaluation
n  114)
Alive, but did not return
(n  50) P value
4 (56%) 32 (64%) .35
0 (44%) 18 (36%)
9 (29-41) 39 (28-41) .80
2 (956-4460) 2984 (1335-3955) .09
9 (6-9) 9 (4-9) .28
4 (47%) 26 (52%)
6 (14%) 5 (10%) .88
8 (7%) 4 (8%)
6 (32%) 15 (30%)
.5 (1-180) 9 (1-188)
7 (59%) 32 (64%) .26
1 (1-4) 1 (1-3) .169
4 (67%) 30/50 (60%)
9 (64%) .10
3 (30%) 14 (47%)
4 (6%) 16 (53%)
.5 (18-183) 80 (28-191) .491
.5 (1-97) 61.5 (23-134) .88
4 (13%) 1/50 (2%) .02
; EEG, electroencephalogram.se w
rned
(
6
5
3
318
5
1
3
8
6
76/11
4
2
78
45
15/11seizures in the 48-hour study period was 79  83, with a
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Dmedian of 52 and a range of 1 to 217. Frontal seizures occurred
in 10 (67%) of 15 patients. All patients were treated with
phenobarbital after identification of seizure activity. In addi-
Figure 1. A, Box plot of MDI scores for all patients (n  114),
stratified by the occurrence of a seizure. B, Box plot of PDI scores
for all patients (n 114), stratified by the occurrence of a seizure.
Within a box, the solid bar represents the median value, the upper
boundary of the closed box represents the 75th percentile, and
the lower boundary represents the 25th percentile. The vertical lines
extend to the 10th and 90th percentiles, with outliers plotted as circles.tion, 3 patients received benzodiazepine therapy.
184 The Journal of Thoracic and Cardiovascular Surgery ● JanuAt the 1-year evaluation, the neuromuscular examination
results were abnormal or suspect in 52 (46%) of 114 pa-
tients. Abnormal or suspect examination results occurred in
41 (41%) of 99 patients without seizures, compared with 11
Figure 2. A, Box plot of MDI scores for patients with HLHS or
variants (n  36), stratified by the occurrence of a seizure. B, Box
plot of PDI scores for patients with HLHS or variants (n  36),
stratified by the occurrence of a seizure.(73%) of 15 patients with postoperative seizures (P .027).
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was 79.2  18.9. For patients without seizures, the MDI
was 92.3  13.5, compared with 90.3  10.7 for patients
with seizures (P  .5; Figure 1, A). Similarly, the PDI was
Figure 3. A, Box plot of MDI scores for patients with seizures
(n  15), stratified by frontal or nonfrontal onset of the seizure.
B, Box plot of PDI scores for patients with seizures (n  15),
stratified by frontal or nonfrontal onset of the seizure.79.9  18.8 for patients without seizures, compared with
The Journal of Thoraci74.4  19.3 for those with seizures (P  .5; Figure 1, B).
Within the subgroups of patients with HLHS or variants, the
findings were similar. The MDI was 92.3  14.9, and the
PDI was 74.8  19.3 for patients without seizures, com-
pared with 91.9  12.4 and 73.9  18.3, respectively, for
those with seizures (both P  .5; Figure 2). The number of
seizures was not predictive of either the MDI or the PDI.
However, frontal-onset seizures were predictive of a lower
score on the MDI (P  .03), but not on the PDI (P  .2),
compared with non–frontal-onset seizures (Figure 3). The
frontal onset of a seizure was not associated with increased
abnormalities on the neuromuscular examination (P  .4).
Discussion
The occurrence of a seizure in the postoperative period after a
neonatal infant heart operation is a marker of CNS injury.1-4
Recent studies at our institution and others have shown that
the incidence of seizures in the early postoperative period,
as documented by continuous video-EEG monitoring, is
less than reported in previous eras.1,5,7 Previous studies
demonstrated that the occurrence of a postoperative seizure
was a predictor of subsequent abnormal neurodevelopmen-
tal development.2,3,9 In this study, evaluation of children
with complex CHDs at 1 year of age after neonatal and
infant heart operations suggested that the adverse effect of a
postoperative seizure may be less than previously reported.
For the entire cohort, there was approximately a 2-point
mean decrease in the MDI and a 5-point mean decrease in
the PDI, and these decreases were not statistically signifi-
cant. However, the occurrence of a seizure was associated
with a significantly increased incidence of abnormal or
suspect neuromuscular examination results.
In the Boston Circulatory Arrest Study, postoperative
EEG seizures occurred in 20% of the patients. Evaluation of
the cohort at 1 year of age showed that the occurrence of an
EEG seizure predicted a lower PDI score (with a mean
decrease of 13 points).2,9 Although the MDI scores of
children with EEG seizures were lower than those of chil-
dren without seizures, the differences were not statistically
significant. A longer total duration of seizures and seizures
with a frontal onset were associated with a trend toward a
worse PDI score.2,9 Subsequent evaluation of this cohort at
4 years of age demonstrated that the occurrence of an EEG
seizure increased the risk of a lower IQ score and increased
the risk of abnormalities on neurologic examination.3 It is
interesting to note that the occurrence of a postoperative
seizure was not associated with worse performance on tests
of visual and spatial skills.10
There are important differences between this study and
the Boston Circulatory Arrest Study. The Boston Circula-
tory Arrest Study evaluated only patients with TGA with or
without a ventricular VSD. The current study enrolled chil-
dren with a variety of complex CHDs, including functional
c and Cardiovascular Surgery ● Volume 131, Number 1 185
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latory Arrest Study underwent operation between 1988 and
1992, whereas the children in this study underwent opera-
tion between 2001 and 2003. In the interval between the
studies, there have been significant changes in prenatal
diagnosis; preoperative management; intraoperative man-
agement, including the management of bypass and deep
hypothermic circulatory arrest; and postoperative care. The
Boston Circulatory Arrest Study was a prospective random-
ized trial that evaluated techniques of CPB and neurodevel-
opmental outcomes. The current study was subgroup of a
prospective observational study that evaluated the effects of
APOE polymorphisms on neurodevelopmental outcome. In
this study, bypass strategies were at the discretion of the
surgeon. It is important to note that investigators in the
Boston Circulatory Arrest Study were blinded to the out-
comes of the video-EEG and that the children with EEG
seizures were not treated with antiepileptic medications
(personal communication, Gil Wernovsky, Children’s Hos-
pital of Philadelphia, 2005 and Jane Newburger, Children’s
Hospital Boston, 2005). In the current study, because of the
previous finding that the occurrence of a seizure was a risk
factor for worse outcome, the physicians caring for the child
were notified if video-EEG seizures were identified, and
treatment was instituted at their discretion. All of the chil-
dren in this study in whom a seizure was identified received
antiepileptic medications, and this may have decreased the
number of seizures and the duration of seizure activity.
The magnitude of the adverse effect of a postoperative
seizure in this study was less than that described in the
Boston Circulatory Arrest Study. However, as in that study,
frontal seizures were associated with a worse outcome com-
pared with nonfrontal seizures. Several factors may have
lessened the effect of seizures. Improvements in preopera-
tive and postoperative care may ameliorate the adverse
effects of a seizure on the CNS. The patient population in
this study was heterogeneous and included patients with
complex forms of single ventricle. Many patients required
more than 1 operation before 1 year of age. Factors other
than seizures may impair neurodevelopmental outcomes in
these patients and confound determination of the effects of
a seizure. Finally, patients in this study were treated with
antiepileptic medications, which may terminate the seizures
and lessen secondary CNS injury.
The long-term neurodevelopmental sequelae of postop-
erative seizures are likely secondary in large part to the
underlying CNS injury provoking them. However, recent
research in pertinent newborn animal models demonstrates
that recurrent seizures induced by proconvulsant drugs that
do not otherwise injure the brain may have long-term un-
desirable effects on brain structure, learning, and suscepti-
bility to spontaneous seizures.11-15 Similarly, in other ani-
mal models, neonatal seizures create long-term changes in
186 The Journal of Thoracic and Cardiovascular Surgery ● Januthe profile of -aminobutyric acid A subunit composition,
the brain’s principal inhibitory neurotransmitter receptor
site.16,17 In addition, phenobarbital administration may be
neuroprotective, apart from its antiseizure effects.18 Al-
though the major force behind the ultimate neurodevelop-
mental abnormalities after postoperative seizures may
largely be their underlying cause, the magnitude of the
contribution of the seizures themselves to the final extent of
disability is not known in human neonates.
There are several limitations to this study. Although this
cohort was one of the largest to undergo postoperative EEG
monitoring and subsequent neurodevelopmental evaluation,
the statistical power to discern differences in outcome was
limited because of the small number of patients in whom
seizures occurred. One-year evaluation was performed in
only 70% of the cohort; however, all but 1 of the surviving
seizure patients returned. The Bayley scales provide an
excellent assessment of status at 1 year, but their predictive
value for neurodevelopmental status at an older age is
limited. Children who are at risk for a poor long-term
outcome may not be identified on testing at 1 year of age.19
More detailed testing of this cohort at an older age may
demonstrate differences between the groups. Finally, this
was not a treatment trial. Patients were treated with antiepi-
leptic medication after identification of a seizure, but treat-
ment was not standardized, and there was no control group.
Therefore, it is not possible to determine conclusively whether
treatment affected the neurodevelopmental outcome.
The occurrence of a postoperative seizure is a marker of
CNS injury. However, the magnitude of the adverse effect
of a seizure on subsequent neurodevelopmental outcome
may be less than previously reported.2,9 In this study, post-
operative seizures were not predictive of a worse outcome at
1 year of age as assessed by the Bayley Scales of Infant
Development. However, postoperative seizures were asso-
ciated with an increase in abnormal findings on the neuro-
muscular examination. Among the patients with seizures,
frontal onset of a seizure was associated with a worse
outcome. Treatment with antiepileptic medication may im-
prove outcome; however, further studies are necessary.
Evaluation at an older age is needed, and the cohort is
currently undergoing a detailed developmental assessment
at 4 years of age.
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Discussion
Dr Richard A. Jonas (Washington, DC). I’d like to begin by
congratulating you and your colleagues in undertaking this ex-
tremely labor-intensive and very expensive evaluation. I know
only too well just how difficult it is to do a study like this. Efforts
like yours will certainly help to improve the quality of life of our
patients and should be encouraged by all of us.
You made it quite clear in your presentation that you believe
that seizures are damaging to the central nervous system, and this
The Journal of Thoraciis supported by masses of evidence in the neuroscience literature.
So why was it not possible for you to demonstrate any impact of
postoperative seizures on developmental outcome in this clinical
study?
I believe you’ve begun to answer the question already. Some of
the factors you mentioned include, first, that you had a very
heterogenous patient population, and many of those—which you
did not mention in the presentation but stated in the manuscript I
received (thank you)—did undergo multiple operations, including
multiple exposures to circulatory arrest. You also mentioned the
fact that seizures that were detected were treated. That is a very
important difference from previous studies.
Another important point is that a disproportionate percentage of
your patients who returned for developmental assessment had
suffered seizures. Those who did not return perhaps had parents
who were not worried about their child’s developmental progress.
You did mention that your neurological exam did demonstrate
a very important impact of seizures on neurological status at 1 year
of age. So, clearly, postoperative seizures are not benign.
The interesting questions that are raised in my mind by your
study are (1) why did such a high percentage of patients have
seizures, and (2) why were your developmental scores so disap-
pointingly low? Eleven percent of your patients suffered seizures.
And while this is an improvement over the 20% of EEG seizures
detected in the circulatory arrest study in the 1980s, it is still
double the incidence of seizures detected in our prospective ran-
domized trial of pH strategy that we undertook in the 1990s. The
MDI score of your patients was 13 points less than in the pH trial,
and the PDI score, a test of motor function, was 16 points less.
Perhaps, as you implied, this difference can be attributed to
different patient populations. In our trials, the majority of patients
had transposition, whereas more than a third of your patients had
hypoplastic left heart syndrome. But another explanation that I
hope you’re going to explore might be related to the technique of
cardiopulmonary bypass support. Our pH trial demonstrated that
the alpha-stat strategy, which you chose to use in this study, was
associated with a higher incidence of morbidity in many different
forms; even death achieved a significance level of .06. The pub-
lication of that study in 1997 has resulted in the majority of
pediatric centers changing to use of the pH-stat strategy. In fact,
work published from your own laboratories has demonstrated
improved neurological protection with the pH-stat strategy. When
I say your own, I mean Dean Kurth’s lab at CHOP [Children’s
Hospital of Philadelphia].
So my first question is, can you please justify your use of the
alpha-stat strategy in this trial?
Dr Gaynor. Well, I think if you look at our results, if you look
at the patients in this trial who would have met the entry criteria for
the pH-stat/alpha-stat study, which were a weight greater than, I
believe, 2.2 kilos, no genetic anomalies, and relatively simple
straightforward 2-ventricle disease, I looked at that subgroup, and
the incidence of seizures in this study, even with alpha-stat, was no
different than the incidence of seizures in the pH arm of your
study. So I don’t think we can say that in this study it was
associated with an increased risk of seizures, at least in comparable
patient populations.
I think an important thing to look at is that we did use the
Bayley Scales of Infant Development II, which came out in 1993.
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DAnd I know for the circulatory arrest study and, I believe, for the
pH-stat study, you used the Bayley Scales of Infant Development
I, which was validated in 1969. It’s been shown that the perfor-
mance in those 2 tests is different and that you have to achieve at
a higher level on the current test to get the same score.
Dr Jonas. Kids are getting smarter.
Dr Gaynor. Well, basically. But to compare between the 2
scores, you have to add, I believe, 12 points to the PDI score and
11 points to the MDI score, which would explain almost all the
differences that we see in mean scores between our groups based
on the testing. So I think you can say that our scores are very
comparable to the scores that you had.
I think our seizure incidence in comparable patients is exactly
the same as in the pH-stat study. And I think the neurodevelop-
mental study that you showed, looking at the outcomes at 1 to 2
years in the pH-stat study, I believe the conclusion was that neither
strategy, neither alpha-stat nor pH-stat, could be statistically asso-
ciated with either an improvement or decrement in neurodevelop-
mental outcome as assessed by the Bayley scales. You couldn’t
identify a statistical difference in outcome.
And indeed, when you looked at the subgroups, there were
differential effects. In the tetralogy transposition group, pH-stat
was better. However, in the VSD group, alpha-stat children actu-
ally performed better.
So I think the data, while I agree with the perioperative data,
the data on long-term neurodevelopmental outcomes of alpha-stat
versus pH-stat are very mixed. And I don’t think there is conclu-
sive evidence that one strategy over the other is associated with
improved outcome. That was the conclusion of your paper.
Dr Jonas. Actually the developmental data had a very strong
trend in the 2 largest subgroups of patients toward improved
outcome with the pH-stat strategy. It was 1 very small subgroup
that had a trend in the other direction.
That study in fact confirms the problem of drawing major
inferences by using developmental data when you have a heterog-
enous population in that there is going to be scatter. And perhaps
we can explain all of these outcomes on the basis of patient
characteristics only. But what I’m suggesting is I don’t think this
is a hard-enough end point for you to be able to draw a conclusion
or even imply that seizures are benign.
But let me go on to my next question. Three years ago I
reported at this meeting the results of a prospective randomized
trial which demonstrated the importance of perfusate hematocrit in
influencing developmental outcome. And in spite of what you and
I have just said about the scatter of data with developmental
outcomes, that study was shut down by the NIH [National Insti-
tutes of Health] because of a powerful impact on the psychomotor
development score with an improved outcome with a hematocrit of
27% versus a hematocrit of 21%.
I was surprised, therefore, that your manuscript makes no
mention of the hematocrit that was employed during bypass and
does not cite that paper. So can you please describe for us the
hemodilution strategy that was employed for your patients?
Dr Gaynor. Actually, because of your study, our hemodilution
strategy changed. When we initiated the study, hemodilution to a
hematocrit of approximately 25 was achieved in most children. By
the end of the study, the average hematocrit after hemodilution was
between 29 and 30. So it actually changed.
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looking at incidence of seizures, and we could not identify an
effect of hematocrit on seizures as a risk factor for seizure. But I
agree that I think that is a very important study. And we actually
changed our management strategy during the course of this study
on the basis of your study.
Dr Jonas. Well, in conclusion, I certainly applaud you for
undertaking this very difficult work and encourage you to continue
to explore means by which we can improve outcomes for our
patients. But I do think that it would be a major disservice for our
future patients if anyone were to leave here with the impression
that EEG seizures are of no consequence and that any difference in
development relative to normal is simply a consequence of the
presence of a particular form of congenital heart disease. Thank you.
Dr Gaynor. I agree. As we stated up front, I think that
occurrence of a seizure is a marker of an injury. However, I think
improvements in how we care for the children may have lessened
the adverse impact.
But more importantly, I think it may be that our testing at 1 year
is very limited, and that’s why this entire cohort is currently
undergoing evaluation at 4 years of age. And as in the circulatory
arrest study, they were still able to demonstrate an adverse effect
of a seizure on outcome at 4 years of age. We may be able to
demonstrate that at 4 years of age. I don’t know yet. But I do agree
that a seizure is a marker, and I don’t think anybody should go
away with the idea that a seizure is a good thing to have. But I’m
just saying that it may be that the magnitude of the adverse
outcome may be less than previously reported.
Dr Francois Lacour-Gayet (Denver, Colo). You said, in the
beginning of your presentation, that there was a correlation be-
tween the length of circulatory arrest and the occurrence of sei-
zures. We personally, in Europe and now in the US, are faithful to
a technique that tries not to use circulatory arrest at all and have
recently used cerebral perfusion for repair of the aortic arch and for
the Norwood operation. Basically, the only surgery where I still
use circulatory arrest is for repair of total anomalous pulmonary
venous return.
Furthermore, there are a number of centers in Japan and Europe
that are now doing surgery with patients under normothermia. And
of course, all these surgeries are done on full-flow cardiopulmonary
bypass, which means a flow that is more than 150 mL · kg1 · min1.
My question is, why do you still use circulatory arrest in most
of your patients? And what is the rationale for maintaining this
technique of circulatory arrest, as we know that it potentially can
hurt the neurological development of the patient?
Dr Gaynor. Circulatory arrest was not used in all these pa-
tients. It was used in approximately 40% of the patients—mainly
the patients with hypoplastic left heart syndrome and other com-
plex defects.
But I think it’s important, as we introduce new techniques such
as regional cerebral perfusion, that you can’t just assume that a
technique like that is going to result in an improved outcome. I
mean, there have been very careful studies, as Dr Jonas mentioned,
evaluating circulatory arrest and low flow, blood gas management
strategies, and hematocrit with neurodevelopmental outcomes,
with seizure monitoring. I think unless you do those types of
outcomes, we cannot assume that a new technique has an advan-
tage. It is theoretically attractive, but it may not have an advantage.
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advantageous, they need to be subjected to the same type of
scrutiny other techniques have been in the past.
Dr Antonio F. Corno (Liverpool, United Kingdom). At this
point, I have mostly to duplicate what Francois has already said.
I’m impressed by the number of resources that you in Phila-
delphia, like our colleagues in Boston, are using to study the
negative consequence of cardiopulmonary bypass. In Liverpool,
we are using a completely different strategy, which is again nor-
mothermia, high flow, and almost-normal hematocrit. And this is
going to the root of the problem.
I have the impression that you guys are using many resources
to study if a brand of cigarette is more or less dangerous than
another one, when no smoking is much better. And for no smok-
ing, I mean a strategy of cardiopulmonary bypass much closer to
physiology than either deep hypothermia or low flow.
Dr Gaynor. I agree that there may be advantages to high-flow
normothermic bypass. There may be advantages to regional cere-
bral perfusion. But you need to do this kind of study with the EEG
monitoring, with neurodevelopmental testing, to show that there isThe Journal of ThoraciDr Corno. Since we do not have the same resources that
you have, why don’t you organize a prospective study using
deep hypothermia or low-flow versus normothermia with high
flow?
Dr Gaynor. That may be a study in the future.
Dr Carl L. Backer (Chicago, Ill). One question that I have is,
do you think we should be routinely monitoring all neonates for
seizures? I’m impressed that some of your good results are from
early diagnosis and therapy of subclinical seizures.
Dr Gaynor. I think that may be. And a treatment trial would
obviously be a next step, based on a trial that is actually designed
as a treatment trial. I think that, as Dr Jonas mentioned, this is a
very time- and money-intensive labor to do these types of moni-
toring. So I think from studies like this we could probably see, if
we look at our TGAs, our TETs [tetralogies of Fallot], and our
VSDs, that the incidence of seizure is so low that it’s probably not
cost-effective.
And again, I don’t think I would advocate routine monitoring
without setting up a treatment trial of routine monitoring and
institutional therapy to look at outcomes. But perhaps in theCH
Dan advantage. There is no other way to show there is an advantage. high-risk subgroups, that would be our next step.c and Cardiovascular Surgery ● Volume 131, Number 1 189
